Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2001
10/10/2001EP1139743A1 Exo-s-mecamylamine formulation and use in treatment
10/10/2001EP1083172A4 N-substituted derivatives of 5-oxyiminobarbituric acid
10/10/2001EP1033993B1 Use of the e.coli strain dsm 6601 for treating diarrhoea in veterinary medicine
10/10/2001EP0840620B1 Il-8 antagonists for treatment of asthma
10/10/2001EP0770071B1 Sulfonamide derivatives of azolones anti-helicobacter agents
10/10/2001EP0765320B1 Benzimidazolone derivatives with central dopaminergic activity
10/10/2001EP0764163B1 Tachykinin (nk 1) receptor antagonists
10/10/2001EP0724582B1 Preparation of omeprazole and lansoprazole and intermediates useful therein
10/10/2001CN1317013A Peptide fragments of cholera toxic B or enterotoxin B as vaccine adjuvants
10/10/2001CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors
10/10/2001CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity
10/10/2001CN1316991A Azetidine derivatives, preparation and medicines containing them
10/10/2001CN1316906A Stable liquid formulations of botulinum toxin
10/10/2001CN1316898A Oral micro-emulsion composition of silybin
10/10/2001CN1316518A Dual-plasmid gene vaccine resisting against hepatitis B virus, and its preparing process and application
10/10/2001CN1316437A Humanized neutralizing generatically engineering Fab antibody of hepatitis A virus
10/10/2001CN1316431A Compound of polypeptide as antigen of hepatitis B virus and heat shock protein and its application
10/10/2001CN1316419A Arenesulfonyl amino-iso hydroximic acid derivative
10/10/2001CN1316273A Match of polyasparamide and paramagnetic metal and its preparing process and application
10/10/2001CN1316271A Chewing gum for preventing decayed tooth and its preparing process
10/10/2001CN1316269A Medicine for treating viral hepatitis
10/10/2001CN1316263A Chinese medicine for treating hepatitis B
10/10/2001CN1316257A Chinese medical for treating toothache and its preparing process
10/10/2001CN1316256A Health-preserving ginseng capsule and its preparing process
10/10/2001CN1316248A Nursing liquid for oral cavity of baby
10/10/2001CN1316241A Health-care liquid of oral cavity and its preparing process
10/10/2001CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/10/2001CN1072664C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compound
10/10/2001CN1072489C Series products for preventing and curing liver disease and production technology
10/10/2001CN1072484C Method for making tablet and granulate containing sodium 2-mercaptoethanesulfonate
10/09/2001US6300470 Amino acid sequence for the treatment of inflammatory pathology; microbiocides
10/09/2001US6300344 Heterocyclic compounds
10/09/2001US6300336 Method of treating or inhibiting functional disturbances or illnesses of the lower intestinal tracts, particularly abdominal visceral pain which accompanies them
10/09/2001US6300334 Thieno[2,3-d]pyrimidine-2,4-diones
10/09/2001US6300325 Heterocyclic receptor antagonist
10/09/2001US6299872 Administering combination of interferon alpha and ribavirin to reduce symptoms of hepatitis c infection
10/09/2001CA2095354C Method and composition for controlled delivery of biologically active agents
10/07/2001CA2304906A1 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/04/2001WO2001073133A1 Compositions and methods for identifying and targeting cancer cells
10/04/2001WO2001073132A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/04/2001WO2001073131A1 High specificity marker detection
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001WO2001073029A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001WO2001073002A2 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
10/04/2001WO2001072960A2 Il-8 receptor antagonists
10/04/2001WO2001072845A1 Use of cd25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract
10/04/2001WO2001072839A2 Human g-protein coupled receptors
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072835A1 Family of human sodium cation channels and use thereof
10/04/2001WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/04/2001WO2001072822A2 Genes involved in intestinal inflammatory diseases and use thereof
10/04/2001WO2001072778A2 Method of identifying inhibitors of tie-2
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072758A1 Tricyclic protein kinase inhibitors
10/04/2001WO2001072757A1 Tricyclic imidazopyridines
10/04/2001WO2001072756A1 Prodrugs of imidazopyridine derivatives
10/04/2001WO2001072755A1 Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders
10/04/2001WO2001072754A1 Alkylated imidazopyridine derivatives
10/04/2001WO2001072752A2 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS
10/04/2001WO2001072744A1 N-heterocyclic derivatives as nos inhibitors
10/04/2001WO2001072737A1 Triarylimidazole derivatives as cytokine inhibitors
10/04/2001WO2001072730A1 Selective preventives/remedies for progressive lesions after organ damage
10/04/2001WO2001072728A2 Novel piperazine derivatives
10/04/2001WO2001072723A1 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/04/2001WO2001072720A1 Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001072705A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/04/2001WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
10/04/2001WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors
10/04/2001WO2001072680A1 Substituted chalcones as therapeutic compounds
10/04/2001WO2001072328A2 Methods of treating diseases with activated protein c
10/04/2001WO2001072327A2 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies
10/04/2001WO2001072310A1 Pharmaceutical gel composition
10/04/2001WO2001072301A1 Intracorporeal medicaments for photodynamic treatment of disease
10/04/2001WO2001072296A1 Method of inhibiting the expression of inflammatory cytokines and chemokines
10/04/2001WO2001072294A2 Method of treating hepatitis delta viral infection
10/04/2001WO2001072144A1 Use of polyphosphate as a tooth erosion inhibitor in acidic compositions
10/04/2001WO2001047878A8 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/04/2001WO2001034565A3 Protease inhibitors
10/04/2001WO2001024780A3 Soft gel capsule resistant to gastric juices
10/04/2001WO2001022990A3 Methods related to immunostimulatory nucleic acid-induced interferon
10/04/2001WO2001022959A3 Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions
10/04/2001WO2001019828A3 Kinase inhibitors as therapeutic agents
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001WO2001013957A3 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
10/04/2001WO2001012214A3 MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a)
10/04/2001WO2001005764A3 Sulfuric acid mono-[3-({1- [2-(4-fluoro-phenyl)-ethyl]- piperidin-4-yl}- hydroxy- methyl)-2- methoxy-phenyl]ester
10/04/2001WO2001000244A3 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
10/04/2001WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
10/04/2001WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/04/2001WO2000032634A9 Humanized antibodies to gamma-interferon
10/04/2001US20010027565 Capable of binding envelope protein of hepatitis virus; therapy and/or diagnostic tool for hepatitis infection
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010027197 Antiproliverative, -carcinogenic and -tumor agents; mitogenesis-activated protein kinase inhibitors; noncytotoxic; binding with high affinity at the adenosine triphosphate binding site of the kinases
10/04/2001US20010027180 GLP-2 formulations
10/04/2001US20010026794 Two heterologous DNA encoding gene products; prolonged half-life
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
10/04/2001EP1138327A1 Use of 2-(arylalkenyl)azacycloalkanes derivatives for treating stress-related gastrointestinal disorders
1 ... 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 ... 1258